❤️‍🩹 Other forms of Aspergillosis: Aspergillus Endocarditis, Understanding a Rare Heart Infection

🫀 What Is It?

Aspergillus endocarditis is a rare infection of the heart’s inner lining (endocardium) caused by the fungus Aspergillus. This condition affects the heart valves (native or prosthetic), the inner wall of the heart, or even devices such as pacemaker leads. The fungus forms large masses called vegetations and can spread to the brain or other organs.

📉 How Rare Is It?

This is among the rarest forms of aspergillosis:

⚠️ Who Is at Risk?

AE usually occurs in individuals who:

• Are immunocompromised (e.g., cancer chemotherapy, transplant recipients, high-dose steroids)

• Have heart valve abnormalities or a prosthetic valve

• Had cardiac surgery or devices placed

• Are critically ill or have severe fungus in the bloodstream

Even with these factors, AE remains extremely uncommon, but its rapid progression makes awareness and early treatment crucial.

🩺 How It’s Diagnosed

Diagnosis is challenging due to:

• Negative blood cultures (blood tests usually don’t detect Aspergillus)

• Symptoms often include fever, new heart murmur, or emboli (e.g., stroke)

• Echocardiograms (TTE/TEE) may reveal large vegetations or abscesses

• Valve or embolus tissue tested via PCR or galactomannan confirms diagnosis

⏳ Prognosis

• AE has a very high mortality rate, ranging from 50–90%, often due to delayed diagnosis

• Even with treatment, survival is around 50–60% with surgery and antifungals; without surgery, survival falls below 5–10%

💊 Current Treatment Guidelines

🛠️ 1. Early Surgical Intervention + Antifungal Therapy

• Surgery to remove infected tissue and replace valves is essential

• Voriconazole (an antifungal) is the preferred medication; liposomal amphotericin B is an alternative

• Combined therapy (two antifungals) may improve outcomes in certain cases

🕰️ 2. Long-Term or Lifelong Antifungal Treatment

• Lifelong antifungals may be needed to prevent recurrence, especially when prosthetic valves are involved

🧪 3. Monitoring and Follow-Up

• Regular monitoring through clinical exams, echocardiograms, and possibly biomarkers

• Watch for signs of relapse or emboli (e.g., neurological symptoms)

📘 Case Insights

• A patient with a prosthetic aortic valve had ≥60% survival with surgery + voriconazole and long-term suppressive treatment

• Another recovered from native valve involvement with combined antifungal therapy and surgery, despite being previously healthy

• Without surgery and antifungals, AE is almost always fatal — mortality approaches 100%

✅ What This Means for Patients

• AE is extremely rare, particularly compared to other forms like ABPA or CPA.

• It occurs mostly in people with significant risk factors — immunosuppression, prior heart surgery, or invasive devices.

• If suspected, early recognition and referral to a specialist center is urgent.

• Treatment combines surgery and antifungals, and usually requires long-term care.

🧭 Bottom Line

Aspergillus endocarditis is a serious and rare complication. While most people with aspergillosis (like ABPA or CPA) will never develop it, anyone with heart valve issues and severe immune weakness should be vigilant.
With early, specialist treatment, recovery is possible — but only if the condition is identified and treated quickly.